Below are the most recent publications written about "Pregnancy Complications, Infectious" by people in Profiles.
-
Falc?o de Oliveira E, Carvalho AT, Venancio FA, Quili?o ME, Gabeira SCO, Leite SHDS, Sal? MDS, Lima SMB, Alves NDS, Moura LDC, Schwarcz WD, Azevedo AS, Demarchi LHF, Zardin MCSU, Lichs GGC, Taira DL, Nascimento AID, Fernandes WS, Alves NO, Casaril Arrua AE, Medeiros MJ, Cunha RVD, Vasconcelos Z, Santos-Pinto CDB, Nielsen-Saines K. Zika virus infection in early pregnancy increases the likelihood of persistent neutralizing antibodies. PLoS Negl Trop Dis. 2026 Jan; 20(1):e0013906.
-
Madlala HP, Jao J, Roussos G, Mendham AE, Myer L, Abrams E, Geffen H, Mukonda E, Modibedi R, Odayar J, Matyesini S, Dugas LR, Goedecke JH, Catalano P, McComsey GA, Gerschenson M. Gluteal Adipose Tissue Mitochondrial Respiration and Insulin Sensitivity in Pregnant South African Women Living With HIV on Tenofovir-Lamivudine-Dolutegravir. J Acquir Immune Defic Syndr. 2025 Dec 15; 100(5):462-470.
-
Harvey A, Tabatabai M, Wilus D, Thomas S, Hildreth JEK, Alcendor DJ. Vaccinations for Expecting Mothers to Improve Pregnancy Care in Middle Tennessee. Pathogens. 2025 Dec 08; 14(12).
-
Messick EA, Saha S, Slaughter JL, Kielt MJ, Benninger KL, Bell EF, Stoll BJ, Puopolo KM, Mukhopadhyay S, Flannery DD, Wyckoff MH, Cotten CM, Patel RM, Laptook AR, Grisby C, Das A, Walsh MC, S?nchez PJ. Maternal Coronavirus Disease 2019 Test Positivity and Neonatal Intensive Care Unit Outcomes for Infants Born Extremely Preterm. J Pediatr. 2026 01; 288:114840.
-
Lebov JF, Nason M, Stolka KB, Ximenes R, Mussi-Pinhata MM, Moye J, Zorrilla CD, Velez Vega CM, Cordero JF, Scalabrin DMF, Ko AI, Moreira MEL, Galv?o LA, Britt W, Marques ETA, Balmaseda A, Harris E, Arias JF, Schultz-Cherry S, Garces AL, Krebs NF, Ochoa TJ, Ugarte-Gil CA, Fogleman E, Gabriel E, Welton M, Irizarry CM, de Moura Negrini SB, Coutinho CM, de Barros Miranda-Filho D, Montarroyos UR, Cordeiro MT, Gajewski A, Osorio JE, Figueroa L. Zika in Infants and Pregnancy (ZIP) study: results from a prospective international cohort study of prenatal Zika virus infection and adverse fetal and infant outcomes. BMC Pregnancy Childbirth. 2025 Aug 30; 25(1):903.
-
Oliveira EF, Santos-Pinto CDB, Venancio FA, Quili?o ME, Gabeira SCO, Carvalho AT, Leite SHDS, Lima SMB, Alves NDS, Moura LDC, Schwarcz WD, Azevedo AS, Demarchi LHF, Zardin MCSU, Lichs GGC, Taira DL, Souza Fernandes W, Alves NO, Arrua AEC, Nascimento AID, Mareto LK, Azevedo MV, Maciel CG, Medeiros MJ, Vasconcelos Z, Cunha RVD, Nielsen-Saines K. Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure. Int J Epidemiol. 2025 Aug 18; 54(5).
-
Valdes V, Sacks DD, Near J, M?ndez Leal AS, Edlow AG, Zorrilla CD, Nelson CA. Whole Brain Spectral Power Differences During Infancy Following Antenatal SARS-CoV-2 and Zika Virus Exposure: Findings From Cohorts in Boston, Massachusetts and San Juan, Puerto Rico. Int J Dev Neurosci. 2025 Aug; 85(5):e70047.
-
Venancio FA, Quili?o ME, Gabeira SCO, Carvalho AT, Leite SHDS, de Lima SMB, Alves NDS, Moura LDC, Schwarcz WD, Azevedo AS, Demarchi LHF, Zardin MCSU, Lichs GGC, Taira DL, Fernandes WS, Alves NO, Arrua AEC, Nascimento AID, Mareto LK, Azevedo MV, Maciel CG, Medeiros MJ, Rodrigues MMS, Vasconcelos Z, Nielsen-Saines K, Cunha RVD, Santos-Pinto CDB, Oliveira EF. Early and Long-Term Adverse Outcomes of In Utero Zika Exposure. Pediatrics. 2025 Feb 01; 155(2).
-
Jao J, Bonner LB, Dobinda K, Powis KM, Sun S, Legbedze J, Mmasa KN, Makhema J, Mmalane M, Kgole S, Masasa G, Moyo S, Gerschenson M, Mohammed T, Abrams EJ, Kurland IJ, Geffner ME. Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study. Clin Infect Dis. 2024 09 26; 79(3):727-733.
-
Abrams EJ, Jao J, Madlala HP, Zerbe A, Catalano P, Gerschenson M, Goedecke JH, Gomba Y, Josefson J, Kurland IJ, Legbedze J, McComsey GA, Matyesini S, Mukonda E, Robinson D, Myer L. An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol. PLoS One. 2024; 19(8):e0307296.